The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Lung Cancer Screen 106 Tissue Microarray - LS-SLUCA106

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SLUCA106
Product Name:	Lung Cancer Screen 106
Description:	Advanced lung cancer with stage/grade and normal/non-neoplastic lung
Format:	FFPE
Category:	Human Tumor and Normal
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Core Diameter:	1.5 mm
Core Thickness:	5 µm
Cases:	80
Cores:	80
Slides Per Set:	1

LS-SLUCA106 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10
A	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
B	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
C	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
D	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
E	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
F	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
G	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
H	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Lung (Lng);

LS-SLUCA106 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage	Tumor Differentiation
1	A1	Human	M	72 y	Lung (Lng)	Adenocarcinoma	Malignant	T1NxM0	1	Stage 1
1	A2	Human	F	50 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N0M0	2	Stage 1
1	A3	Human	F	49 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T1N0M0	2	Stage 1
1	A4	Human	F	67 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	2	Stage 1
1	A5	Human	F	60 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	2	Stage 1
1	A6	Human	F	53 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	Stage 1
1	A7	Human	M	70 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	Stage 1
1	A8	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	Stage 1
1	A9	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	Stage 1
1	A10	Human	F	55 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	2	Stage 1
1	B1	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0		Stage 1
1	B2	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	Stage 1
1	B3	Human	M	30 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	3	Stage 1
1	B4	Human	M	51 y	Lung (Lng)	Small cell carcinoma	Malignant	T1N0M0		Stage 1	Undifferentiated
1	B5	Human	M	62 y	Lung (Lng)	Small cell carcinoma	Malignant	T1N0M0		Stage 1	Undifferentiated
1	B6	Human	M	34 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	Stage 2
1	B7	Human	F	54 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	Stage 2
1	B8	Human	M	64 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N3M0	2	Stage 3
1	B9	Human	F	50 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N2M0	2	Stage 3
1	B10	Human	M	62 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M1	2	Stage 4
1	C1	Human	F	49 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	Stage 2
1	C2	Human	M	66 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N2M0	3	Stage 3
1	C3	Human	M	65 y	Lung (Lng)	Adenocarcinoma	Malignant	T3N2M0	2	Stage 3
1	C4	Human	F	54 y	Lung (Lng)	Adenocarcinoma	Malignant	T3N0M0	3	Stage 3
1	C5	Human	M	51 y	Lung (Lng)	Adenocarcinoma	Malignant	T4N1M1	3	Stage 4
1	C6	Human	M	47 y	Lung (Lng)	Carcinoma	Malignant	T3N1M0		Stage 3
1	C7	Human	M	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N3M0	2	Stage 3
1	C8	Human	M	49 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	1	Stage 2
1	C9	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	C10	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	D1	Human	M	57 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T3N0M0	2	Stage 3
1	D2	Human	M	59 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	2	Stage 3
1	D3	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	2	Stage 3
1	D4	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	D5	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	D6	Human	M	59 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	2	Stage 3
1	D7	Human	M	67 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	2	Stage 3
1	D8	Human	M	49 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T4N0M0	2	Stage 3
1	D9	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	2	Stage 3
1	D10	Human	M	46 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T3N1M0	2	Stage 3
1	E1	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M1	2	Stage 4
1	E2	Human	M	67 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	E3	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	2-3	Stage 3
1	E4	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	E5	Human	M	37 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	E6	Human	M	55 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0		Stage 2
1	E7	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	Stage 2
1	E8	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma with chronic inflammation	Malignant	T2N2M0		Stage 3
1	E9	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	3	Stage 3
1	E10	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	3	Stage 3
1	F1	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N1M1	3	Stage 4
1	F2	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	Stage 2
1	F3	Human	M	77 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	3	Stage 3
1	F4	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T4N0M0	3	Stage 3
1	F5	Human	M	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	2	Stage 3
1	F6	Human	F	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	3	Stage 3
1	F7	Human	M	53 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	3	Stage 3
1	F8	Human	M	74 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	Stage 2
1	F9	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	Stage 2
1	F10	Human	M	46 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N2M0	3	Stage 3
1	G1	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T4N0M0	3	Stage 3
1	G2	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	Stage 2
1	G3	Human	M	61 y	Lung (Lng)	Large cell carcinoma	Malignant	T4N0M0		Stage 3
1	G4	Human	M	54 y	Lung (Lng)	Large cell carcinoma with necrosis	Malignant	T3N0M0		Stage 3
1	G5	Human	M	53 y	Lung (Lng)	Small cell carcinoma	Malignant	T3N2M1		Stage 4	Undifferentiated
1	G6	Human	F	54 y	Lung (Lng)	Small cell carcinoma	Malignant	T3N2M0		Stage 3	Undifferentiated
1	G7	Human	F	42 y	Lung (Lng)	Small cell carcinoma	Malignant	T4N1M0		Stage 3	Undifferentiated
1	G8	Human	F	50 y	Lung (Lng)	Small cell carcinoma	Malignant	T4N1M0		Stage 3	Undifferentiated
1	G9	Human	M	73 y	Lung (Lng)	Small cell carcinoma	Malignant	T3N1M0		Stage 3	Undifferentiated
1	G10	Human	M	29 y	Lung (Lng)	Small cell carcinoma	Malignant	T2N2M0		Stage 3	Undifferentiated
1	H1	Human	M	55 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H2	Human	M	40 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H3	Human	M	49 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H4	Human	M	24 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H5	Human	M	50 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H6	Human	F	14 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H7	Human	M	48 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H8	Human	M	42 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H9	Human	M	35 y	Lung (Lng)	Normal	Benign non-neoplastic
1	H10	Human	M	22 y	Lung (Lng)	Normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.